Literature DB >> 30102780

Genetics Meets Therapy? Exome-wide Association Study Reveals a Loss-of-Function Variant in 17-Beta-Hydroxysteroid Dehydrogenase 13 That Protects Patients From Liver Damage and Nonalcoholic Fatty Liver Disease Progression.

Silvia Sookoian1,2, Marco Arrese3, Carlos J Pirola1,4.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30102780     DOI: 10.1002/hep.30209

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

Review 1.  Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics.

Authors:  Simona Riccio; Rosa Melone; Caterina Vitulano; Pierfrancesco Guida; Ivan Maddaluno; Stefano Guarino; Pierluigi Marzuillo; Emanuele Miraglia Del Giudice; Anna Di Sessa
Journal:  World J Clin Pediatr       Date:  2022-03-23

Review 2.  Liver tissue microbiota in nonalcoholic liver disease: a change in the paradigm of host-bacterial interactions.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

Review 3.  New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease.

Authors:  Yu-Cheng Lin; Chi-Chien Wu; Yen-Hsuan Ni
Journal:  Front Pediatr       Date:  2020-12-09       Impact factor: 3.418

Review 4.  Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis.

Authors:  Shan Tang; Jing Zhang; Ting-Ting Mei; Wen-Yan Zhang; Su-Jun Zheng; Hai-Bin Yu
Journal:  BMC Gastroenterol       Date:  2021-12-20       Impact factor: 3.067

5.  Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension.

Authors:  Bernhard Scheiner; Albert F Stättermayer; Philipp Schwabl; Theresa Bucsics; Rafael Paternostro; David Bauer; Benedikt Simbrunner; Ralf Schmidt; Rodrig Marculescu; Arnulf Ferlitsch; Markus Peck-Radosavljevic; Mathias Pinter; Michael Trauner; Thomas Reiberger; Peter Ferenci; Mattias Mandorfer
Journal:  Liver Int       Date:  2019-12-03       Impact factor: 5.828

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.